How to Buy Tonix Pharmaceuticals Holding Stock
Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering.
Tonix Pharmaceuticals Holding stock last closed at $18.57, down 4.72% from the previous day, and has increased 10.54% in one year. It has overperformed other stocks in the Biotechnology industry by 0.36 percentage points. Tonix Pharmaceuticals Holding stock is currently +174.7% from its 52-week low of $6.76, and -85.72% from its 52-week high of $130.00.
There are currently 8.77M shares of TNXP outstanding. The market value of TNXP is $162.78M. In the last 24 hours, 686,000 TNXP shares were traded.
How to Buy Tonix Pharmaceuticals Holding Stock
Not sure how to invest in Tonix Pharmaceuticals Holding stock? Here's how.
- Decide where to buy Tonix Pharmaceuticals Holding stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Tonix Pharmaceuticals Holding stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your payment method and add your info.
- Research Tonix Pharmaceuticals Holding stock: The Tonix Pharmaceuticals Holding ticker symbol is TNXP. Is Tonix Pharmaceuticals Holding stock a good investment? Should you buy shares of TNXP? How do TNXP's underlying business fundamentals look? Do top analysts think Tonix Pharmaceuticals Holding is a good buy? Why has TNXP's stock price moved recently? (Hint: Our stock market research tools can help you figure out if TNXP is a good stock to buy).
- Make your TNXP buy order: Decide if you will purchase TNXP shares at the current market price or use a limit order to buy TNXP shares at a given price.
- Get updates on your TNXP position: Create a watchlist to watch your position in Tonix Pharmaceuticals Holding stock.
Step 1: Decide where to buy Tonix Pharmaceuticals Holding stock
You need a brokerage account in order to access the NASDAQ market and buy TNXP stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in TNXP stock today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've created your account on investing apps, you need to deposit funds:
Watch this video walkthrough if you need help depositing money into your brokerage account.
Step 4: Research Tonix Pharmaceuticals Holding stock
Once you have figured out the best place to buy Tonix Pharmaceuticals Holding stock, it's important to research their stock prior to investing, so you actually wrap your head around the risk and opportunity.
Tonix Pharmaceuticals Holding Metrics
TNXP Due Diligence Score
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on TNXP's stock page.
Is TNXP stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge TNXP's true value.
Using relative valuations metrics:
- TNXP may be undervalued based on its P/E ratio of 0.07x, relative to Biotechnology industry P/E ratio of -90.6x
- TNXP could be undervalued based on its P/B ratio of 0.97x, relative to Biotechnology industry P/B ratio of 4.96x
You can access additional valuation analysis on TNXP's stock here.
TNXP Financial Overview
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the TNXP balance sheet.
- There are more short-term assets than long-term liabilities on the TNXP balance sheet.
- TNXP has a low debt to equity ratio of 0.12.
- TNXP has cash burn of 65388000. It has enough cash and short-term investments to cover this for at least one year.
- TNXP has $125.33M in cash and short term investments. This is sufficient to cover its annual cash burn of $65.39M.
Negative Health Checks:
- Total TNXP debt is higher than 5 years ago, relative to shareholder equity.
- TNXP profit margin has gone up by 3.68 percentage points in the past year, but the company is still unprofitable.
You can dig deeper into what analysts are saying on the Tonix Pharmaceuticals Holding stock forecast page.
TNXP Trading Indicators
TNXP Growth Numbers
Last year, TNXP revenue was $9.83M. In the last one years, TNXP's revenue has increased by -21.09% per year. This was slower than the Biotechnology industry average of 69.23%.
Dive into TNXP's earnings and revenue performance here.
Who is buying/selling TNXP?
In the past 12 months, executives and large shareholders at TNXP have bought more shares than they have sold.
Carolyn E. Taylor, Director of TNXP, was the latest TNXP insider to buy. They bought $15,060.54 worth of TNXP stock on Aug 21, 2025.
Research more about who owns TNXP shares here.
Does TNXP provide a stable income stream?
No, Tonix Pharmaceuticals Holding doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your TNXP buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, use a limit order.
Press the Open button and eToro will execute your order.
If you need additional help with investing in stocks on eToro, watch the how to video below:
Step 6: Get updates on your TNXP position
Now that you own some shares in TNXP, you'll want to stay up-to-date on your investment.
Put TNXP on a watchlist to get alerted to the latest events about your TNXP stock.
TNXP Feed
How to Buy Stock in Tonix Pharmaceuticals Holding
To summarize, here are the 6 steps you need to take to buy Tonix Pharmaceuticals Holding stock right now:
- Decide where to buy Tonix Pharmaceuticals Holding stock
- Open a brokerage account
- Put funds into your brokerage account
- Research Tonix Pharmaceuticals Holding stock
- Make your TNXP buy order
- Get updates on your TNXP position
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Tonix Pharmaceuticals Holding, create a watchlist today.
Other "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.